New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
PT Pyridam Farma Tbk
PYFA.JK
Shape
US Flag

JKT

Unprofitable

Unprofitable

2922B

Drug Manufacturers - Specialty & Generic

260.00IDR
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

46%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

83%

Quote Panel

Shape
Updated October 15, 2024
1W 0.00 % 1M 63.52 % 3M 142.99 % 1Y 41.64 %

Key Metrics

Shape
  • Market Cap

    2921.54B


  • Shares Outstanding

    11.24B


  • Share in Float

    4.40B


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    260


  • Average Volume

    101.16M


  • Beta

    1.248


  • Range

    81.0-1545.0


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.pyfa.co.id


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.67x

P/S Ratio

2.18x

P/B Ratio

2.7

Debt/Equity

-20.6%

Net Margin

$24.1

EPS

How PYFA.JK compares to sector?

P/E Ratio

Relative Strength

Shape

PYFA.JK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-77%

1
vs 4.35

Q2.22

arrow
arrow

+5847%

12.25
vs 0.21

Q3.22

arrow
arrow

+5985%

522.73
vs 8.59

Q4.22

arrow
arrow

N/A

-5.43
vs -4.21

Q1.23

arrow
arrow

N/A

-4.94
vs 1

Q2.23

arrow
arrow

N/A

-9.78
vs 12.25

Q3.23

arrow
arrow

N/A

-3.54
vs 522.73

Q4.23

arrow
arrow

N/A

-15.94
vs -5.43

Q1.24

arrow
arrow

N/A

-18.18
vs -4.94

Q2.24

arrow
arrow

N/A

-6.22
vs -9.78

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+47%

172.4B  vs 117.4B

Q2.22

arrow
arrow

+28%

134.7B  vs 105.1B

Q3.22

arrow
arrow

+33%

243.8B  vs 183.9B

Q4.22

arrow
arrow

-27%

164.5B  vs 224.2B

Q1.23

arrow
arrow

-4%

164.9B  vs 172.4B

Q2.23

arrow
arrow

+10%

148.8B  vs 134.7B

Q3.23

arrow
arrow

-15%

206.9B  vs 243.8B

Q4.23

arrow
arrow

+10%

181.6B  vs 164.5B

Q1.24

arrow
arrow

-8%

151.6B  vs 164.9B

Q2.24

arrow
arrow

+72%

255.7B  vs 148.8B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+61%

0.61
vs 0.04

Q4.22

arrow
arrow

-3%

-0.03
vs 0.61

Q1.23

arrow
arrow

-3%

-0.03
vs -0.03

Q2.23

arrow
arrow

-6%

-0.06
vs -0.03

Q3.23

arrow
arrow

-2%

-0.02
vs -0.06

Q4.23

arrow
arrow

-11%

-0.11
vs -0.02

Q1.24

arrow
arrow

-15%

-0.15
vs -0.11

Q2.24

arrow
arrow

-5%

-0.05
vs -0.15

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News